MediHealth Ltd and NovaThera™ Ltd are pleased to announce the development and manufacture of NovaPod™ - a compact, manual feed, disposable, batch culture bioreactor that allows researchers and scientists, working on stem cells to culture cells in three dimensions. NovaThera’s™ proprietary encapsulation technology can be used with NovaPod™ for the production of pluripotent stem cells and their progeny without the need for continuous operator intervention increasing efficiency and reducing costs.

MediHealth and NovaThera™ Ltd have co-developed and designed the NovaPod™ system in collaboration with stem cell scientists as part of a UK government sponsored project. MediHealth Ltd is starting production phase and NovaThera™ Ltd are gearing up for market launch at the end of the year.

“MediHealth and NovaThera™ Ltd have exchanged the ideas on product design and development to optimize the functions and features of NovaPod™. Thus, NovaPod™ is more user-friendly and reliable than other products currently on the market – “It is our first significant step into stem cell bioprocessing with bioreactors” said Dr. Wesley Randle, Programme Director of Stem Cell Bioprocessing at NovaThera™ Ltd, UK. Commenting on project collaboration
Dr. Joseph Liu, General Manager of MediHealth Ltd, said, “We are delighted to work with NovaThera™ Ltd to explore these important stem cell technologies that underpin regenerative medicine. We believe that this joyful and successful collaboration will continue with the next generation of NovaPod™ system”.

-ends-

Notes to editors:

Background on NovaThera Ltd
NovaThera Ltd™ is an Imperial College spin out company. NovaThera specialises in pioneering applications of biomaterials and stem cell biology for regenerative to provide innovative therapeutic solutions (wound management, bone repair, lung repair). For more information about NovaThera, please visit http://www.novathera.com.

Background on MediHealth
About: MediHealth Limited (“MediHealth”), a member of AML Group, specializes in Development and Distribution of Medical Devices & Healthcare products providing one-stop partnership service. Headquartered in in Hong Kong the Group has comprehensive, multi-technology, Integrated Manufacturing facilities and Collaboration Network with Technology Research Institutes & Venture Capitalists around the world If you would like more information about this subject and explore how we can complement your needs. http://www.medihealth.com.hk

Contacts:

NovaThera	MediHealth
Dr Gareth Roberts, CSO g.roberts@novathera.com	Dr. Joseph Liu joseph.liu@medihealth.com.hk

This press release contains forward looking statements that involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the results, performance or achievements expressed or implied by these forward looking statements.